Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

193 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tuning inflammation in tuberculosis: the role of decoy receptors.
Di Liberto D, Caccamo N, Meraviglia S, Guggino G, La Manna MP, Sireci G, Salerno A, Dieli F. Di Liberto D, et al. Among authors: guggino g. Microbes Infect. 2009 Sep;11(10-11):821-7. doi: 10.1016/j.micinf.2009.05.004. Epub 2009 May 18. Microbes Infect. 2009. PMID: 19450705 Free article. Review.
Gammadelta T cell modulation in anticancer treatment.
Caccamo N, Dieli F, Meraviglia S, Guggino G, Salerno A. Caccamo N, et al. Among authors: guggino g. Curr Cancer Drug Targets. 2010 Feb;10(1):27-36. doi: 10.2174/156800910790980188. Curr Cancer Drug Targets. 2010. PMID: 20088797 Review.
V gamma 9V delta 2 T lymphocytes efficiently recognize and kill zoledronate-sensitized, imatinib-sensitive, and imatinib-resistant chronic myelogenous leukemia cells.
D'Asaro M, La Mendola C, Di Liberto D, Orlando V, Todaro M, Spina M, Guggino G, Meraviglia S, Caccamo N, Messina A, Salerno A, Di Raimondo F, Vigneri P, Stassi G, Fourniè JJ, Dieli F. D'Asaro M, et al. Among authors: guggino g. J Immunol. 2010 Mar 15;184(6):3260-8. doi: 10.4049/jimmunol.0903454. Epub 2010 Feb 12. J Immunol. 2010. PMID: 20154204
In vivo manipulation of Vgamma9Vdelta2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients.
Meraviglia S, Eberl M, Vermijlen D, Todaro M, Buccheri S, Cicero G, La Mendola C, Guggino G, D'Asaro M, Orlando V, Scarpa F, Roberts A, Caccamo N, Stassi G, Dieli F, Hayday AC. Meraviglia S, et al. Among authors: guggino g. Clin Exp Immunol. 2010 Aug;161(2):290-7. doi: 10.1111/j.1365-2249.2010.04167.x. Epub 2010 May 10. Clin Exp Immunol. 2010. PMID: 20491785 Free PMC article. Clinical Trial.
Expression of interleukin-32 in the inflamed arteries of patients with giant cell arteritis.
Ciccia F, Alessandro R, Rizzo A, Principe S, Raiata F, Cavazza A, Guggino G, Accardo-Palumbo A, Boiardi L, Ferrante A, Principato A, Giardina A, De Leo G, Salvarani C, Triolo G. Ciccia F, et al. Among authors: guggino g. Arthritis Rheum. 2011 Jul;63(7):2097-104. doi: 10.1002/art.30374. Arthritis Rheum. 2011. PMID: 21452292 Free article.
Increased percentages of tumor necrosis factor-alpha+/interferon-gamma+ T [corrected] lymphocytes and calprotectin+/tumor necrosis factor-alpha+ monocytes in patients with acute Kawasaki disease.
Guggino G, Cimaz R, Accomando S, Pagnini I, Simonini G, Di Liberto D, De Martino M, Dieli F, Sireci G. Guggino G, et al. Int J Immunopathol Pharmacol. 2012 Jan-Mar;25(1):99-105. doi: 10.1177/039463201202500112. Int J Immunopathol Pharmacol. 2012. PMID: 22507322 Free article.
193 results